Dr. Sai HS Boddu

Brief Biography:

EDUCATION
B.Pharmacy                
Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India
July 1999 – July 2003
M.Pharmacy(Pharmaceutics)
NDMVP samaj’s College Of Pharmacy, Nashik, Maharashtra, India
August 2003 – August 2005
Ph.D. (Pharmaceutics and Drug Design)
Department of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas city, MO
August 2006 – December 2010

CURRENT RESEARCH INTERESTS
•Development of novel drug delivery systems for treatment of pancreatic, prostrate, ovarian and colorectal cancer
•Application of nanotechnology in the development of targeted and/or controlled delivery systems for protein and peptide molecules
•Design of lipid- or polymer-based micro/nanoparticles to improve the therapeutic properties of drugs
•Development of novel tripeptide-protease inhibitor prodrugs incorporated in self-nanoemulsifying drug delivery systems (SNEDDS) that will enable eradication or depletion of the latent HIV reservoir

GRANTS
Submitted
1. Collaborating Investigator, “Novel Trans-scleral Delivery Strategy using Bimatoprost
Nanoparticles given Subconjunctivally for the Treatment of Glaucoma”, St. Luke’s Hospital Foundation, $24,600.00, 11/01/2009 – 10/31/2009
2.  Principal Investigator, “Novel nanoemulsion based formulations of tripeptide prodrugs for eradicating latent HIV reservoirs” , Bill Gates Foundation, Nov, 2011 - Nov, 2012
The main objective of this grant proposal is to engineer novel tripeptide-protease inhibitor prodrugs incorporated in self-nanoemulsifying drug delivery systems (SNEDDS) to enable eradication or depletion of the latent reservoir. There is no scientific and budgetary overlap with current proposal. Amount requested: $ 100, 000.00, Status: Under review

HONORS AND AWARDS
1.UMKC-Vice Chancellor for Student Affairs and Enrollment Management Honor Recipient, Fall-2010
2.UMKC-Chancellor's Doctoral Fellowship, (2008-10)
3.UMKC-Chancellor Non-Resident award, (2006-10)
4.Best poster award for Research Day 2010 at UMKC
5.AAPS-UMKC Best seminar speaker award for Fall-2008
6.24th Annual Achievers of Excellence award at UMKC, 2006bioanalytical method for the quantitative estimation of Pantoprazole in human plasma samples by LC-MS/MS: Application to bioequivalence study. Journal of Chromatography B, 878: 1499–1505
6.Boddu SH, Gunda S, Earla R, Mitra AK 2010. Ocular microdialysis: A continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye. Bioanalysis 2(3): 487-507.
7.Earla R, Boddu SH, Cholkar K, Hariharan S, Jwala J, Mitra AK 2010. Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids-Quantitative meaurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 52(4):525-33.
8.Boddu SH, Jwala J, Vaishya R, Earla R, Karla PK, Pal D, Mitra AK 2010. Novel nanoparticulate gel formulations of steroids for the treatment of macular edema. J Ocul Pharmacol Ther. 26(1):37-48.
9.Janoria KG, Boddu SH, Wang Z, Paturi DK, Samanta S, Pal D, Mitra AK 2009. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J Ocul Pharmacol Ther 25(1):39-49.
10.Karla PK, Earla R, Boddu SH, Johnston TP, Pal D, Mitra A 2009. Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells. Current eye research 34(1):1-9.
11.Gaudana R, Jwala J, Boddu SH, Mitra AK 2009. Recent perspectives in ocular drug delivery. Pharmaceutical research 26(5):1197-1216.
12.Agarwal S, Boddu SH, Jain R, Samanta S, Pal D, Mitra AK 2008. Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor. International journal of pharmaceutics 359(1-2):7-14.
13.Janoria KG, Gunda S, Boddu SH, Mitra AK 2007. Novel approaches to retinal drug delivery. Expert opinion on drug delivery 4(4):371-388.
14.Derle DV, Boddu SH, Kotwal RS, Ingole RD, Chavan SS 2006. A compartive in vitro evaluation of transdermal permeation of  valdecoxib and its compled with HP-beta-cyclodextrin from microemulsion based gel. Indian Drugs 48(8):625-629.
15.Deelip Derle, Boddu SH, Manoj Magar 2006. Studies on the Preparation, Characterization and Solubility of β-Cyclodextrin -Satranidazole Inclusion Complexes. Indian Journal of Pharmaceutical Education and Research 40(6):232-236.
16.Derle DV, Boddu SH, Rohini Pimpale 2006. Microemulsion as a vehicle for transdermal permeation of nimesulide, Indian J. Pharm. Sci. 68(5):622-625.
17.Derle DV, Gujar, K. N. Boddu SH 2006. Adverse effects associated with the use of nonsteroidal antiinflammatory drugs: An overview, Indian J. Pharm. Sci. 68(4):409-414.
18.Derle DV, Khangoankar S, Boddu SH, Pimpale R 2005. Development of dissolution medium for Pioglitazone, Indian Drugs 42(5):313-315.
19.Sagar GV, Sastry BS, Boddu SH, 2003. Determination of Lacidipine in Pharmaceutical formulations by Oxidimetry, Journal- institution of Chemists India 75(4):133-134.

Academic positions:

Graduate Assistant     
NDMVP Samaj's College of Pharmacy
Nashik,Maharashtra, India   
2003-2005

Research Associate    
Wockhardt Research Center
Chikalthana, Aurangabad
Maharashtra, India
2005-2006

Lecturer (Part-time)    
S.N.D. College of Pharmacy,
(Physical Pharmacy University of Pune, Yeola,& Pharmaceutical Maharashtra, India Dosage forms)
2005 -2006

Research Assistant     
School of Pharmacy,
University of Missouri-Kansas City Kansas City, MO
2006 -2010

Assistant Professor
(Pharmaceutics)
University of Toledo
College of Pharmacy Toledo, OH
Feb, 2011

ACADEMIC ADVISING
Spring 2011, University of Toledo M.S. Program in Industrial Pharmacy:
1. Ishan S. Shah (M.S. student). Thesis title: Development and Characterization of Oil-in-Water Nanoemulsions from Self-Microemulsifying Mixtures

TEACHING RESPONSIBILITIES
Fall, 2011     
PHPR 3070 PPD 1
Professional Practice Development 1               
Credit hours: 4
Fall, 2011                        

PHPR - Pharmaceutical Rate Processes                                      
Credit hours: 3
Spring, 2012
 
PHPR 3080 PPD 2 Professional Practice Development 2               
Credit hours:4

Research interests:

I have a strong teaching and research experience in Pharmaceutics, Drug delivery, Nanotechnology, and Pharmacokinetics.

Formulation Skills
- Expertise and knowledge in the development and characterization of various novel drug delivery systems such as micro/nanoparticles, polymeric micelles and microemulsions.
- Expertise in formulation of various dosage forms including syrups, solutions, eye drops and injections.
- ANDA experience: Development of Risperidone oral solution (1 mg/mL) (currently approved for US market).
- Pharmacokinetic Skills
- Expertise and knowledge in cell culture techniques for drug delivery.
- Expertise in carrying out micro-dissection and pharmacokinetics in rabbits and mice.

Analytical Skills
- HPLC, UV spectroscopy, spectrofluorimetry, particle size analysis, nuclear magnetic resonance (NMR), osmometry, confocal fluorescence microscopy, differential scanning calorimetry, enzyme-linked immunosorbent assay (ELISA), radioactive assay, LC-MS/MS. Extraction techniques: Solid Phase Extraction (SPE) and liquid-liquid extraction

Any other information:

ACADEMIC/ADMINISTRATIVE SERVICE
Fall 2011 to Summer 2012
1. Curriculum committee
2. Research, Scholarship and graduate education committee
PROFESSIONAL ACTIVITIES
ORGANIZATION AFFILIATIONS
1.Member of the American Association of Pharmaceutical Scientists, 2006-Present
2.Member of the Association for Research in Vision and Ophthalmology, 2006-2010
3.Member of American Association of Colleges of Pharmacy, 2011-Present
JOURNAL REVIEW
1.Reviewer for Journal of Ocular Pharmacology
2.Reviewer for Current Eye Research
3.Reviewer for Pharmaceutical Research
4.Reviewer for Journal of Controlled Release
5.Reviewer for Advanced Drug Delivery Reviews
6.Editorial board member for International Journal of Pharmacy

What I think of the idea behind WebmedCentral:

A good place to share the research work.